Back
Vanda Pharmaceuticals 10K Form
Buy
55
VNDA
Vanda Pharmaceuticals
Last Price:
5.10
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | VNDA/Vanda Pharmaceuticals Quarterly |
| 2023-11-09 | 10Q | VNDA/Vanda Pharmaceuticals Quarterly |
| 2023-07-28 | 10Q | VNDA/Vanda Pharmaceuticals Quarterly |
| 2023-05-03 | 10Q | VNDA/Vanda Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | VNDA/Vanda Pharmaceuticals Quarterly |
| 2022-08-04 | 10Q | VNDA/Vanda Pharmaceuticals Quarterly |
Receive VNDA News And Ratings
See the #1 stock for the next 7 days that we like better than VNDA
VNDA Financial Statistics
Sales & Book Value
| Annual Sales: | $192.64M |
|---|---|
| Cash Flow: | $-7.04M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.31 |
| Price / Book: | 0.58 |
Profitability
| EPS (TTM): | -0.18760 |
|---|---|
| Net Income (TTM): | $-10.93M |
| Gross Margin: | $177.84M |
| Return on Equity: | -2.01% |
| Return on Assets: | -1.69% |
Vanda Pharmaceuticals Earnings Forecast
Key Vanda Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 18 years for VNDA is 92.32%.
- The Selling, General & Administrative Expenses for VNDA have been equal to 58.60% of Gross Profit Margin.
- The Research & Development expenses have been 39.88% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of VNDA is 1.30% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 11 years.
Vanda Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VNDA |
| CUSIP: | 921659 |
| Website: | vandapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.68 |
| Quick Ratio: | 4.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 135.25 |
|---|---|
| Forward P/E Ratio: | 0 |
VNDA Technical Analysis vs Fundamental Analysis
Buy
55
Vanda Pharmaceuticals (VNDA)
is a Buy
Is Vanda Pharmaceuticals a Buy or a Sell?
-
Vanda Pharmaceuticals stock is rated a Buy
The current Vanda Pharmaceuticals [VNDA] share price is $5.47. The Score for VNDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.